Biotronik receives FDA approval for new cardiac devices - 0 views
-
jacob logan on 18 Mar 19Biotronik has secured approval from the US Food and Drug Administration (FDA) for the use of its Acticor and Rivacor cardiac rhythm management (CRM) devices to treat heart arrhythmias.